Background And Objective: Magnetic resonance imaging (MRI)-driven active surveillance (AS) is increasingly used for management of prostate cancer (PC). The aim of our study was to determine the oncological safety of contemporary MRI-driven AS and identify patients at higher risk of AS failure.
Methods: This retrospective cohort study included AS patients with MRI-localised PC from three US and UK centres.